Dishman Carbo Amcis Ltd. DCAL’s stock price targets are 83.78 on the downside and 86.63 on the upside.
Share PriceValueToday/Current/Last84.25Previous Day85.35 insights from Dishman Carbogen
What Is The Product Of Dishman Carbogen?
CARBOGEN AMCIS B.V. manufactures Vitamin D2, Vitamin D3, Vitamin D analogues, cholesterol, and lanolin-related products in Veenendaal, The Netherlands. The site also manufactures intermediates and active pharmaceutical ingredients, including highly potent drugs.
What Are The Financial Results Of Dishman Pharma?
302.79 crores, compared to 200.32 crores in FY 2020-21. In FY 2021-22, loss before tax was 84.39%, while in FY 2020-21, loss before tax was 168.69 crores. In FY 2021-22, loss after tax was 31.55%, while in FY 2020-21, loss after tax was 232.81 crores.
What Is The Quarterly Results Of Dishman Carbogen?
In the most recent quarter, the company reported a net profit after taxes of Rs -10.05 billion.
Is Dishman Carbogen A Good Buy?
MoneyWorks4Me’s Price Trend analysis shows that it is Weak, indicating that the price of Dishman Carbogen Amcis Ltd is likely to fall quickly.
Who Is The Owner Of Dishman Carbogen?
Shri Janmejay R. Vyas, the Managing Director of the Dishman Group, established the Dishman Group in 1983.
- Breaking Down the Recent Vesuvius Share Price Rally on the NSE - March 23, 2023
- Understanding the Factors Driving Vikas Multicorp’s Share Price on BSE - March 23, 2023
- Analyzing the Major Factors Affecting National Express Share Price in 2021 - March 23, 2023